ReviewPlants (Basel, Switzerland)2026
Nanotechnology-Enabled CRISPR Delivery: Emerging Opportunities in Agriculture and Forest Biotechnology.
Review in Plants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genome editing is one of the key technologies in contemporary plant biotechnology, which has been revolutionized using CRISPR/Cas systems that offer rapid, flexible, and precise options to improve agricultural characteristics, enhance stress tolerance, and accelerate breeding of crops and trees. Despite the significant benefits of CRISPR/Cas systems, their use is restricted by difficulties in genome-editing materials into plant cells. The conventional approaches include Agrobacterium-mediated transformation, particle bombardment and PEG-mediated transfection; these have contributed significantly to advancements in the field; however, dependent on specific plants and requiring tissue cultures, these methods lead to random transgene insertion and poor transformation efficiency. In addition, nanotechnology represents a novel method of delivering CRISPR cargos into plant cells using minimal invasiveness and potentially without DNA. This review provides a synopsis of the most employed CRISPR/Cas systems within plants, comparing the traditional delivery mechanisms and the various nanotechnological delivery vehicles, such as lipid nanoparticles, carbon nanotubes, DNA nanostructures, mesoporous silica nanoparticles, magnetically responsive nanoparticles and green nanomaterials. This review discusses the present challenges of delivery efficacy, biocompatibility, cargo integrity, and regulatory issues, and provides suggestions for future research directions regarding nanotechnology-assisted genome editing for precision breeding, sustainable agriculture, production of crops tolerant to climate conditions, and forest biotechnology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.